SARDOCOR Trademark

Adhesive plasters for medical purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; cardiovascular agents for medical purposes; cardiovascular medicines; cells for medical or clinical use; cells for medical purposes; chemical reagents for medical or veterinary purposes for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; diagnostic preparations for medical purposes for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; dietary supplements for humans; dietary supplements for pets in the form of treats; dietetic foods adapted for medical purposes; disinfectants; food for babies; fungicides; gene therapy products, namely, genetically engineered tissues for transplant purposes; herbicides; medicinal preparations for regenerative and reparative therapies; nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; preparations for destroying vermin; sanitary preparations for medical use; sanitary preparations for veterinary use; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants comprised of living tissues; synthetic peptides for pharmaceutical purposes; synthetic peptides for the treatment of respiratory conditions; veterinary preparations for regenerative and reparative therapies; pharmaceutical preparations for the treatment of heart disorders and systemic diseases associated with cardiac pathology; pharmaceutical preparations, namely, drugs for the prevention and treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; living cells for medical purpose

Blood bank services; healthcare services; human tissue bank services; medical care services; medical services; medical testing and medical evaluation of cardiovascular diseases and systemic diseases associated with cardiac pathology; organ and tissue bank services; stem cell therapy services; medical services in the field of cardiovascular diseases; consultancy services in the field of cardiovascular diseases

Bacteriological research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biological research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biomedical research services for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biotechnology research for use in gene and cell therapies for cardiovascular diseases and systemic diseases associated with cardiac pathology; chemical research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; medical and scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others in the field of gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; conducting early evaluations in the field of new pharmaceuticals for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; research and development in the field of of biopharmaceutical products and medicine for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; drug discovery services; engineering services, particularly technical project planning and design engineering of lines for the processing of web products; industrial research in the field of regenerative and reparative therapies; medical and pharmaceutical research services in the field of gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; medical research laboratory services; pharmaceutical research services; pharmaceutical drug development services for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; pharmaceutical product evaluation and analysis; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development and consultation related thereto in the field of genetic and cellular modulation techniques for cardiovascular applications; research and development of new products for others; research and development of vaccines and medicines for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; conducting scientific research in the field of gene therapy; stem cell research services; technical research in the field of pharmaceutical studies; technological research in the field of regenerative and therapies